Bidirectional membrane transport: Simulations of transport inhibition in uptake studies explain data obtained with flavonoids

European Journal of Pharmaceutical Sciences

Volumn 29, Issue 3-4 SPEC. ISS., 2006, Pages 251-258

  Ofer, Monika ^a   Langguth, Peter ^a   Spahn Langguth, Hilde ^a,b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b German University in Cairo   (Egypt)

Author keywords

Bidirectional; Exsorptive transport; Flavonoids; Membrane transport; Transport inhibition

Indexed keywords

CARRIER PROTEIN; DRUG CARRIER; FLAVONOID; GLYCOPROTEIN P; ISOQUERCITRIN; MULTIDRUG RESISTANCE PROTEIN 1; NARINGENIN; TALINOLOL;

ARTICLE; CANCER CELL CULTURE; CONCENTRATION RESPONSE; DIFFUSION; DRUG UPTAKE; HUMAN; HUMAN CELL; ISOTOPE LABELING; MEMBRANE TRANSPORT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; SIMULATION;

ANIMALS; BIOLOGICAL TRANSPORT; COMPUTER SIMULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FLAVONOIDS; HUMANS; MODELS, THEORETICAL; P-GLYCOPROTEIN; PROPANOLAMINES;

EID: 33750198264     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2006.06.010     Document Type: Article

References (19)

1. Anderle P., Sengstag T., Mutch D.M., Rumbo M., Praz V., Mansourian R., Delorenzi M., Williamson G., and Roberts M.A. Changes in the transcriptional profile of transporters in the intestine along the anterior-posterior and crypt-villus axes. BMC Genomics 6 (2005) 69
2. Cvetkovic M., Leake B., Fromm M.F., Wilkinson G.R., and Kim R.B. Oatp and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine. Drug Metab. Dispos. 27 (1999) 66-871
3. Dressler C. Interactions of Losartan and its Major Metabolite EXP3174 with Membrane Transporters in vitro, in situ, and in vivo (2002), Department of Pharmaceutical Chemistry, Faculty of Pharmacy. Martin-Luther-University Halle-Wittenberg, Halle/Saale, Germany
4. Evers R., Kool M., van Deemter L., Janssen H., Calafat J., Oomen L.C.J.M., Paulusma C.C., Oude Elferink R.P.J., Baas F., Schinkel A.H., and Borst P. Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA. J. Clin. Invest. 101 (1998) 1310-1319
5. Gabrielsson J., and Weiner D. Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Application (1997), Swedish Pharmaceutical Society
6. Ginsburg H., and Stein W.D. How many functional transport pathways does Plasmodium falciparum induce in the membrane of its host erythrocyte. Trends Parasitol. 21 (2005) 118-121
7. Hilgendorf C., Spahn-Langguth H., Rhedin M., Regardh C.G., Lowenadler B., and Langguth P. Selective downregulation of the MDR1 gene product in Caco-2 cells by stable transfection to prove its relevance in secretory drug transport. Mol. Pharm. 2 (2005) 64-73
8. Hu X.F., de Luise M., Martin T.J., and Zalcberg J.R. Effect of cyclosporine and verapamil on the cellular kinetics of daunorubicin. Curr. Drug Targets 4 (1990) 23-30
9. Javaheri S., De Hemptinne A., Vanheel B., and Leusen I. Changes in the brain ECF pH during metabolic acidosis and alkalosis: a microelectrode study. J. Appl. Physiol. 55 (1983) 1849-1853
10. Koepsell H., Schmitt B.M., and Gorboulev V. Organic cation transporters. Rev. Physiol. Biochem. Pharmacol. 25 (2003) 36-90
11. Krishna R., and Mayer L.D. Modulation of P-glycoprotein (PGP) mediated multidrug resistance (MDR) using chemosensitizers: recent advances in the design of selective MDR modulators. Curr. Med. Chem. Anticancer Agents 1 (2001) 163-174
12. Lan L.B., Ayesh S., Lyubimov E., Pashinsky I., and Stein W.D. Kinetic parameters for reversal of the multidrug pump as measured for drug accumulation and cell killing. Cancer Chemother. Pharmacol. 38 2 (1996) 181-190
13. Litman T., Skovsgaard T., and Stein W.D. Pumping of drugs by P-glycoprotein: a two-step process?. J. Pharmacol. Exp. Ther. 307 (2003) 846-853
14. Loe D.W., Deeley R.G., and Cole S.P. Verapamil stimulates glutathione transport by the 190-kDa multidrug resistance protein 1 (MRP1). J. Pharmacol. Exp. Ther. 293 (2000) 530-538
15. Ofer M. Modulation of Membrane Transport-A Mechanism to Explain Kinetic Interactions between Drugs and Flavonoids (2004), Department of Pharmacy, Johannes Gutenberg-University, Mainz, Germany
16. Ofer, M., Langguth, P., Hennes, K., Spahn-Langguth, H., 2006. "Transgenic ovarian carcinoma cells: characterization of an experimental model to define P-glycoprotein-related transport" Meth. Findings, in press.
17. Seelig A., and Landwojtowicz E. Structure-activity relationship of P-glycoprotein substrates and modifiers. Eur. J. Pharm. Sci. 12 (2000) 31-40
18. Stein W.D. Kinetics of the multidrug transporter (P-glycoprotein) and its reversal. Physiol. Rev. 77 (1997) 545-590
19. Zhang L., Schaner M.E., and Giacomini K.M. Functional characterization of an organic cation transporter (hOCT1) in a transiently transfected human cell line (HeLa). J. Pharmacol. Exp. Ther. 286 (1998) 354-361